Filtered By:
Nutrition: Vitamin K
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 1818 results found since Jan 2013.
Formulary restrictions and stroke risk in patients with atrial fibrillation
CONCLUSIONS: Limiting access to NOACs may exacerbate current underuse of anticoagulants and increase the risk of stroke among patients with newly diagnosed AF. Pharmacy benefit managers and Part D plans need to continuously review the appropriateness of formulary policies to ensure patient access to effective medications.PMID:36252171 | DOI:10.37765/ajmc.2022.89195
Source: The American Journal of Managed Care - October 17, 2022 Category: Health Management Authors: Bo Zhou Seth Seabury Dana Goldman Geoffrey Joyce Source Type: research
Effects of a Pharmacist-Led Educational Interventional Program on Electronic Monitoring-Assessed Adherence to Direct Oral Anticoagulants: A Randomized, Controlled Trial in Patients with Nonvalvular Atrial Fibrillation
In this study, the selection of DOACs was not randomized, and the lack of assessment of the association between adherence to DOACs and clinical outcomes was a limitation. Japan Registry of Clinical Trials (jRCT) indentifier: jRCTs031180142. (Clin Ther. 2022;44:XXX-XXX) © 2022 Elsevier Inc.PMID:36244853 | DOI:10.1016/j.clinthera.2022.09.011
Source: Clinical Therapeutics - October 16, 2022 Category: Drugs & Pharmacology Authors: Tsuyoshi Shiga Toshimi Kimura Noritoshi Fukushima Yuji Yoshiyama Kazunori Iwade Fumiaki Mori Yoichi Ajiro Shoji Haruta Yuichiro Yamada Emi Sawada Nobuhisa Hagiwara SMAAP-AF Investigators Source Type: research
Associations Between Drug Treatments and the Risk of Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-analysis
AbstractThere is increasing interest in drug therapy for preventing aneurysmal subarachnoid hemorrhage (aSAH). We aimed to comprehensively evaluate the association between drug use and the risk of aSAH. We searched PubMed and Scopus from the databases ’ inception until December 2021. Observational studies reporting the association between any drug therapy and aSAH were included. The odds ratios (ORs) for each drug used in aSAH were meta-analyzed with a random-effect model. According to the systematic review, 25 observational studies were eligib le for the present study. Four therapeutic purpose-based classes (e.g., lipid...
Source: Translational Stroke Research - October 15, 2022 Category: Neurology Source Type: research
Risk of Stroke and Major Bleeding with Vitamin-K Antagonist Use after Mitral Valve Repair
CONCLUSIONS: Our study suggests that VKA after MVr does not reduce risk of cerebral embolic events but is associated with increased risk of major bleeding events.PMID:36223805 | DOI:10.1016/j.athoracsur.2022.09.038
Source: The Annals of Thoracic Surgery - October 12, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Chase R Brown Alexandra E Sperry William G Cohen Jason J Han Fabliha Khurshan Peter Groeneveld Nimesh Desai Source Type: research
Evidence-Based Recommendations: Management of Left Ventricular Thrombus Post–Acute Myocardial Infarction
This article serves as a general review of the pathophysiology, diagnosis, and management of LVT.
Source: Dimensions of Critical Care Nursing - October 8, 2022 Category: Nursing Tags: Educational DIMENSION Source Type: research
Comparison of Dabigatran Versus Warfarin Treatment for the Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation
Atrial fibrillation is one of the most common arrhythmias in the United States and is associated with an increased risk of thromboembolic events.1 The American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines recommend oral anticoagulation with either warfarin or oral non-vitamin K antagonists for patients diagnosed with atrial fibrillation with a high risk for ischemic stroke based on the CHA2DS2-VASc score.2 The recently published article “Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation” discussed the efficacy of...
Source: The American Journal of Cardiology - October 7, 2022 Category: Cardiology Authors: Marwa S.H. Abrahim, Olufemi Sofola-James, Zeina Bani Hani Source Type: research
Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries
CONCLUSION: Inappropriate DOAC-dosing was more prevalent in multimorbid patients, but did not correlate with higher risks of adverse events after adjusting for confounders. DOAC prescription should follow label.PMID:36182083 | DOI:10.1016/j.vph.2022.107120
Source: Vascular Pharmacology - October 1, 2022 Category: Drugs & Pharmacology Authors: Giulia Montrasio Martin F Reiner Andrea Wiencierz Stefanie Aeschbacher Christine Baumgartner Nicolas Rodondi Michael K ühne Giorgio Moschovitis Helga Preiss Michael Coslovsky Maria L De Perna Leo H Bonati David Conen Stefan Osswald Juerg H Beer Pascal Ko Source Type: research
Evidence-Based Recommendations: Management of Left Ventricular Thrombus Post-Acute Myocardial Infarction
This article serves as a general review of the pathophysiology, diagnosis, and management of LVT.PMID:36179309 | DOI:10.1097/DCC.0000000000000553
Source: Dimensions in Critical Care Nursing - September 30, 2022 Category: Nursing Authors: Mohamed Toufic El Hussein Marianne Mikhail Source Type: research
Prognostic implications of adherence to OACs among patients with atrial fibrillation: Insights from MISOAC-AF trial
CONCLUSIONS: In recently hospitalized patients with AF, good adherence to OACs was associated with a reduced risk of all-cause death and CVD. The rates of stroke or bleeding events were not significantly different. VKAs were associated with more adverse events compared to DOACs.PMID:36179772 | DOI:10.1016/j.jjcc.2022.09.009
Source: Journal of Cardiology - September 30, 2022 Category: Cardiology Authors: Vasiliki Patsiou Athanasios Samaras Anastasios Kartas Dimitrios V Moysidis Andreas S Papazoglou Alexandra Bekiaridou Amalia Baroutidou Antonios Ziakas Apostolos Tzikas George Giannakoulas Source Type: research
Evidence-Based Recommendations: Management of Left Ventricular Thrombus Post-Acute Myocardial Infarction
This article serves as a general review of the pathophysiology, diagnosis, and management of LVT.PMID:36179309 | DOI:10.1097/DCC.0000000000000553
Source: Dimensions in Critical Care Nursing - September 30, 2022 Category: Nursing Authors: Mohamed Toufic El Hussein Marianne Mikhail Source Type: research
